Brief: Anixa Biosciences Receives Notice Of Allowance From Canadian Intellectual Property Office For Patent Covering Breast Cancer Vaccine Technology
30/07/2025 14:06
July 30 (Reuters) - Anixa Biosciences Inc ANIX.O: ANIXA BIOSCIENCES RECEIVES NOTICE OF ALLOWANCE FROM CANADIAN INTELLECTUAL PROPERTY OFFICE FOR PATENT COVERING BREAST CANCER VACCINE TECHNOLOGY Source text: ID:nPn4tpwmRa Further company coverage: ANIX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anixa Biosciences
See all newsBrief: Anixa Biosciences Announces First Case Of Stable Disease For Three Months In Ovarian Cancer Car-T Clinical Trial
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Anixa Biosciences Inc reports results for the quarter ended July 31 - Earnings Summary
Anixa Biosciences Inc expected to post a loss of 9 cents a share - Earnings Preview
Factbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine